Brigham and Women’s Aspirin-Exacerbated Respiratory Disease (AERD) Center
The Brigham and Women’s Aspirin-Exacerbated Respiratory Disease (AERD) Center is a research and patient-care group that is focused on discovering new treatments for the disease, understanding how aspirin desensitization works, and investigating the underlying causes of AERD. Our multidisciplinary team is made up of allergists, ENT surgeons, and research scientists who work towards the common goal of understanding and managing AERD.
How We Can Help
Evaluation and diagnosis of AERD, nasal polyps and other allergic diseases
Aspirin Desensitization. This can be done as in an outpatient in clinic, as an inpatient if required, or as part of a clinical trial.
Participation in clinical trials for AERD and nasal polyps.
Adjunctive therapies for AERD, including dietary modifications.
Next generation treatment with biologics. Our physicians follow the most up-to-date research on the emerging field of biologics for AERD, severe asthma, and nasal polyps.
Referral services to ENT specialists with extensive experience with surgical treatment of AERD patients.
Your contributions enable key investments in research and education and allow the team at the AERD Center to continue to fight the disease by conducting pioneering research in the hopes of finding new ways to treat and prevent AERD. Click here to donate to the AERD Center research efforts.
Call the allergy clinic at (617) 732-9850. The team is available to answer your calls Monday – Friday, 8:30pm–4:30pm. If you are a new patient, you must register with Brigham and Women's Hospital. This is the first step to scheduling an appointment. New patients should call a patient coordinator directly at 855-278-8009 to request an appointment. Our scheduling coordinators provide personalized service in English or Spanish.
If interested in clinical trial opportunities for AERD treatment, or to enroll in our AERD Patient registry, please contact Jillian Bensko at (617) 525-9243.